Literature DB >> 23918553

Expression kinetics of chicken β2-microglobulin and Class I MHC in vitro and in vivo during Marek's disease viral infections.

Chuan Yu1, Qiu Liu, Aijian Qin, Xuming Hu, Wencai Xu, Kun Qian, Hongxia Shao, Wenjie Jin.   

Abstract

Marek's disease virus (MDV) is a highly cell-associated herpesvirus that causes a disease in chickens characterized by tumor formation and immunosuppression. The changes of major histocompatibility complex (MHC) expression in different MDV-infected cells are not completely understood. In this study, we investigated the expression of the Class I MHC and β2-microglobulin (β2m) genes in response to MDV infection at different time points by real-time PCR. In both in vitro and in vivo, the expression levels of Class I MHC and β2m genes were upregulated during early MDV infections in comparison to control cells; We also found that the expression of Class I MHC gene was downregulated in BudR (5-bromo-2'-deoxyuridine)-treated MSB1 cells at 48 h and MDV-infected chicken embryo fibroblast cells (CEF) at 120 and 168 h post infection (hpi); Furthermore, compared to control groups, Class I MHC and β2m expression levels were downregulated in peripheral blood lymphocytes (PBLC) from MDV-infected chickens at 14 and 28 days post infection (dpi); Interestingly, both Class I MHC and β2m gene expression levels increased again in PBLC from MDV RB1B-infected chickens at 35 dpi, in which MDV was in the latent or transformed infection stages. In addition, Class I MHC expression was clearly decreased in MDV-infected CEF at 120 hpi although β2m expression was significantly increased. These changes in Class I MHC and β2m gene expression might provide more insights into host-virus interaction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23918553     DOI: 10.1007/s11259-013-9572-z

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  35 in total

1.  Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins.

Authors:  S Ishido; C Wang; B S Lee; G B Cohen; J U Jung
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Proteomic analysis of the host response in the bursa of Fabricius of chickens infected with Marek's disease virus.

Authors:  Zhanjun Lu; Aijian Qin; Kun Qian; Xinhong Chen; Wenjie Jin; Yufeng Zhu; Y M Eltahir
Journal:  Virus Res       Date:  2010-08-17       Impact factor: 3.303

Review 4.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

5.  Beta2 microglobulin: a surprising therapeutic target for prostate cancer and renal cell carcinoma.

Authors:  Michael R Freeman
Journal:  J Urol       Date:  2007-05-11       Impact factor: 7.450

6.  Herpes B virus, macacine herpesvirus 1, breaks simplex virus tradition via major histocompatibility complex class I expression in cells from human and macaque hosts.

Authors:  Mugdha Vasireddi; Julia Hilliard
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

7.  Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis.

Authors:  Takeo Nomura; Wen-Chin Huang; Haiyen E Zhau; Daqing Wu; Zhihui Xie; Hiromitsu Mimata; Majd Zayzafoon; Andrew N Young; Fray F Marshall; M Neale Weitzmann; Leland W K Chung
Journal:  Clin Cancer Res       Date:  2006-12-15       Impact factor: 12.531

8.  Major histocompatibility complex class I is downregulated in Marek's disease virus infected chicken embryo fibroblasts and corrected by chicken interferon.

Authors:  Alon M Levy; Irit Davidson; Shane C Burgess; E Dan Heller
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2003-05       Impact factor: 2.268

9.  Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma.

Authors:  Takeo Nomura; Wen-Chin Huang; Seongil Seo; Haiyen E Zhau; Hiromitsu Mimata; Leland W K Chung
Journal:  J Urol       Date:  2007-05-17       Impact factor: 7.450

10.  MHC expression on spleen lymphocyte subsets in genetically resistant and susceptible chickens infected with Marek's disease virus.

Authors:  Tina Dalgaard; Mette K Boving; Kurt Handberg; Karin H Jensen; Liselotte R Norup; Helle R Juul-Madsen
Journal:  Viral Immunol       Date:  2009-10       Impact factor: 2.257

View more
  3 in total

1.  Marek's disease virus may interfere with T cell immunity by TLR3 signals.

Authors:  Xuming Hu; Wencai Xu; Aijian Qin; Genghua Wu; Kun Qian; Hongxia Shao; Jianqiang Ye
Journal:  Vet Res Commun       Date:  2014-03-02       Impact factor: 2.459

2.  Transcriptional Profiling of Host Gene Expression in Chicken Embryo Fibroblasts Infected with Reticuloendotheliosis Virus Strain HA1101.

Authors:  Ji Miao; Yanqing Bao; Jianqiang Ye; Hongxia Shao; Kun Qian; Aijian Qin
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

3.  Global and quantitative proteomic analysis of dogs infected by avian-like H3N2 canine influenza virus.

Authors:  Shuo Su; Jin Tian; Malin Hong; Pei Zhou; Gang Lu; Huachen Zhu; Guihong Zhang; Alexander Lai; Shoujun Li
Journal:  Front Microbiol       Date:  2015-04-02       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.